Amyloid‐Related Imaging Abnormalities in the DIAN‐TU‐001 Trial of Gantenerumab and Solanezumab: Lessons from a Trial in Dominantly Inherited Alzheimer Disease
Sign Up to like & getrecommendations! Published in 2022 at "Annals of Neurology"
DOI: 10.1002/ana.26511
Abstract: To determine the characteristics of participants with amyloid‐related imaging abnormalities (ARIA) in a trial of gantenerumab or solanezumab in dominantly inherited Alzheimer disease (DIAD). read more here.
Keywords: gantenerumab solanezumab; trial; trial gantenerumab; related imaging ... See more keywords
Aducanumab-Related Amyloid-Related Imaging Abnormalities
Sign Up to like & getrecommendations! Published in 2022 at "Clinical Nuclear Medicine"
DOI: 10.1097/rlu.0000000000004250
Abstract: Abstract When the FDA granted accelerated approval of Biogen's Alzheimer disease drug, aducanumab (marketed as Aduhelm), it deviated from its mission of guaranteeing drug safety and efficacy because the approval was based exclusively on a… read more here.
Keywords: amyloid; aducanumab related; imaging abnormalities; amyloid related ... See more keywords
Risk factors for imaging abnormalities after the first febrile urinary tract infection in infants ≤3 months old: a retrospective cohort study
Sign Up to like & getrecommendations! Published in 2023 at "BMJ Paediatrics Open"
DOI: 10.1136/bmjpo-2022-001687
Abstract: Objectives To assess the association of clinical factors and investigation results (blood and urine) with imaging abnormalities (ultrasound of the kidneys, ureters and bladder; dimercaptosuccinic acid scan; and/or micturating cystourethrogram) and recurrent urinary tract infections… read more here.
Keywords: infants months; non coli; coli uti; first febrile ... See more keywords